Duration
2 years
Lead institutions
Universiteit Antwerpen
University of Nairobi
Academic partners
Primus Ochieng
Project status
Ongoing
Programme
SI
Total budget
69,975.40
Summary
Cervical cancer (CC) is the second most diagnosed cancer and leading cause of cancer related deaths among women in Kenya. There is evidence that the high rates of loss to follow up among cancer patients is often accopmanied by incomplete treatment and unknown outcomes. This makes it difficult to develop intervention mechanisms and policies that safeguard patient access to care and improve on survivorship. This study, which is nested to the main TEAM 2024 project entitled,”Cervical Cancer Management in Kenya: A Clinical Audit of the Process and Outcome of Radiotherapy Treatment”, proposes to identify factors associated with treatment dropout and develop mitigation measures. While the clinical audit in the main study will be focusing on the quality of care given to women diagnosed with CC, this study will document life journeys of those women who drop out of CC treatment and who would otherwise be lost to follow up.
Contact us